TP53 and prostate adenocarcinoma: Network pharmacology identified 37 genes linked to prostate adenocarcinoma, highlighting key genes like EGFR, TP53, ERBB2, IGFBP3, MMP-2, MMP-9, HDAC6, PDGFRB, and FGFR1.